Total Payments
$7,723
2024 Payments
$1,196
Companies
54
Transactions
325
Medicare Patients
4,982
Medicare Billing
$394,318
Payment Breakdown by Category
Food & Beverage$7,089 (91.8%)
Education$634.29 (8.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,089 | 310 | 91.8% |
| Education | $634.29 | 11 | 8.2% |
| Unspecified | $0 | 4 | 0.0% |
Payments by Type
General
$7,723
321 transactions
Ownership
$0
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $931.75 | 23 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $715.90 | 33 | $0 (2024) |
| ABBVIE INC. | $651.99 | 30 | $0 (2024) |
| Janssen Biotech, Inc. | $636.08 | 30 | $0 (2024) |
| PFIZER INC. | $416.53 | 26 | $0 (2024) |
| Blue Earth Diagnostics Limited | $337.95 | 17 | $0 (2024) |
| Boston Scientific Corporation | $335.32 | 10 | $0 (2022) |
| Dendreon Pharmaceuticals LLC | $318.10 | 12 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $286.62 | 15 | $0 (2023) |
| Teleflex LLC | $273.67 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,196 | 44 | Astellas Pharma US Inc ($226.69) |
| 2023 | $813.27 | 37 | Dendreon Pharmaceuticals LLC ($121.80) |
| 2022 | $1,048 | 39 | Astellas Pharma US Inc ($229.39) |
| 2021 | $1,319 | 54 | Teleflex LLC ($195.79) |
| 2020 | $967.77 | 39 | Astellas Pharma US Inc ($266.51) |
| 2019 | $657.63 | 29 | Janssen Biotech, Inc. ($178.20) |
| 2018 | $810.41 | 46 | Janssen Biotech, Inc. ($130.63) |
| 2017 | $911.05 | 37 | NeoTract Inc. ($143.17) |
All Payment Transactions
325 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $25.41 | General |
| Category: Diagnostic Imaging | ||||||
| 12/18/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $25.97 | General |
| Category: HORMONE THERAPY | ||||||
| 12/10/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $15.32 | General |
| Category: Prostate cancer | ||||||
| 11/19/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $27.52 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 11/18/2024 | LANTHEUS MEDICAL IMAGING, INC. | — | Food and Beverage | In-kind items and services | $25.82 | General |
| 11/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $32.47 | General |
| Category: Oncology | ||||||
| 11/07/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: Diagnostic Imaging | ||||||
| 11/05/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $25.23 | General |
| Category: HORMONE THERAPY | ||||||
| 10/08/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $29.05 | General |
| Category: HORMONE THERAPY | ||||||
| 09/16/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: ONCOLOGY | ||||||
| 08/30/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $27.90 | General |
| Category: Oncology | ||||||
| 08/22/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $25.66 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 08/15/2024 | Tolmar, Inc. | ELIGARD (Drug) | Food and Beverage | Cash or cash equivalent | $18.55 | General |
| Category: ONCOLOGY | ||||||
| 08/14/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $11.24 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/02/2024 | 180 Medical, Inc. | — | Food and Beverage | In-kind items and services | $23.57 | General |
| 08/02/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/01/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: Diagnostic Imaging | ||||||
| 07/30/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $28.86 | General |
| 07/18/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: ONCOLOGY | ||||||
| 07/11/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $31.99 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/09/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $26.80 | General |
| 07/02/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: ONCOLOGY | ||||||
| 06/26/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $29.99 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 06/20/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $30.64 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/07/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: Diagnostic Imaging | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 1,365 | 2,156 | $400,351 | $107,477 |
| 2022 | 20 | 1,178 | 1,823 | $317,836 | $91,462 |
| 2021 | 20 | 1,228 | 1,917 | $309,073 | $88,340 |
| 2020 | 21 | 1,211 | 2,108 | $533,500 | $107,039 |
Total Patients
4,982
Total Services
8,004
Medicare Billing
$394,318
Procedure Codes
86
All Medicare Procedures & Services
86 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 287 | 486 | $79,218 | $32,107 | 40.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 105 | 157 | $35,796 | $15,709 | 43.9% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 45 | 59 | $54,870 | $11,813 | 21.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 75 | 88 | $22,880 | $9,292 | 40.6% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 81 | 153 | $12,240 | $6,435 | 52.6% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2023 | 12 | 13 | $16,120 | $3,777 | 23.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $8,456 | $3,688 | 43.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 21 | $6,804 | $3,179 | 46.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 15 | 61 | $7,840 | $2,917 | 37.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 29 | 43 | $6,020 | $2,896 | 48.1% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 22 | 29 | $62,060 | $2,762 | 4.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 26 | 49 | $5,047 | $2,102 | 41.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 15 | 16 | $6,080 | $2,061 | 33.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 21 | 21 | $4,284 | $1,899 | 44.3% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 24 | 25 | $4,750 | $1,659 | 34.9% |
| 81003 | Automated urinalysis test | Office | 2023 | 240 | 481 | $9,620 | $1,054 | 11.0% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 87 | 121 | $12,100 | $955.42 | 7.9% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2023 | 27 | 33 | $19,140 | $669.12 | 3.5% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 14 | 19 | $2,926 | $633.12 | 21.6% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 11 | 20 | $9,560 | $572.41 | 6.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 114 | 159 | $3,180 | $542.19 | 17.1% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Office | 2023 | 12 | 13 | $7,280 | $329.28 | 4.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 32 | 37 | $740.00 | $310.80 | 42.0% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 12 | 13 | $3,120 | $80.34 | 2.6% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 11 | 11 | $220.00 | $35.46 | 16.1% |
About Dr. David Zumerchik, M.D
Dr. David Zumerchik, M.D is a Urology healthcare provider based in Evergreen Park, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1669480950.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Zumerchik, M.D has received a total of $7,723 in payments from pharmaceutical and medical device companies, with $1,196 received in 2024. These payments were reported across 325 transactions from 54 companies. The most common payment nature is "Food and Beverage" ($7,089).
As a Medicare-enrolled provider, Zumerchik has provided services to 4,982 Medicare beneficiaries, totaling 8,004 services with total Medicare billing of $394,318. Data is available for 4 years (2020–2023), covering 86 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Evergreen Park, IL
- Active Since 08/03/2006
- Last Updated 04/16/2025
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1669480950
Products in Payments
- Nubeqa (Drug) $441.94
- XTANDI (Drug) $426.60
- LUPRON DEPOT (Drug) $350.37
- Erleada (Drug) $345.36
- PROVENGE (Drug) $340.48
- ORGOVYX (Drug) $329.88
- BOTOX (Biological) $301.41
- XIAFLEX (Biological) $286.62
- Xofigo (Drug) $273.96
- ELIGARD (Drug) $240.45
- ERLEADA (Drug) $199.42
- KEYTRUDA (Biological) $197.47
- UroLift System (Device) $195.79
- GREENLIGHT (Device) $184.51
- POSLUMA (Drug) $181.16
- Axumin (Drug) $156.79
- Urolift - UL400 (Device) $143.17
- Xtandi (Drug) $134.07
- PYLARIFY (Drug) $134.01
- MYRBETRIQ (Drug) $120.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.